Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning

Cancer Nursing

Volumn 32, Issue 4, 2009, Pages 325-334

  Andersson, Inger ^a,b   Ahlberg, Karin ^b   Stockelberg, Dick ^a   Brune, Mats ^a   Persson, Lars Olof ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Allogeneic stem cell transplantation; EORTC QLQ C30; HDC 19; Health related quality of life; Myeloablative conditioning (MAC); Nursing; Reduced intensity conditioning (RIC); Symptoms

Indexed keywords

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADULT; AGED; ATTITUDE TO HEALTH; FATIGUE; FEMALE; GRAFT VS HOST DISEASE; HEALTH STATUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MOUTH DISEASES; NURSING METHODOLOGY RESEARCH; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; SWEDEN; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 67651115859     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/NCC.0b013e31819b5c81     Document Type: Article

References (34)

1. Dansey R, Baynes R. Nonablative allogeneic haematopoietic stem cell transplantation. Curr Opin Oncol. 2001;13:27-32. (Pubitemid 32060040)
2. Slavin S, Nagler A, Naparstek E, et al. Nonmyeloblative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood. 1998;91: 756-763. (Pubitemid 28078275)
3. Tabbara I, Ingram R. Nonmyeloblative therapy and allogeneic haematopoietic stem cell transplantation. Exp Hematol. 2003;31:559-566. (Pubitemid 36808799)
4. Vindeøv L. Allogenic bone marrow transplantation with reduced conditioning (RC-BMT). Eur J Heamatol. 2001;66:73-82. (Pubitemid 32154099)
5. Meijer E, Dekker A, Lokhorst H, Petersen E, Nieuwenhuis H, Verdonck L. Low incidence of infectious complications after nonmyeloablative compared with myeloablative stem cell transplantation. Transpl Infect Dis. 2004;6:171-178. (Pubitemid 40516685)
6. Dreger P, Brand R, Milligan D, et al, on behalf of the Chronic Leukaemia Working Party of the EBMT. Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukaemia: a population-matched analysis. Leukemia. 2005;19:1029-1033.
7. Levine J, Uberti J, Ayash L, et al. Lowered intensity preparative regimen for allogeneic stem cell transplantation delays acute graft versus host disease but does not improve outcome for advanced hematologic malignancy. Biol Blood Marrow Transplant. 2003;9:189-197.
8. Danaher Hacker E. Quantitative measurement of quality of life in adult patients undergoing bone marrow transplantation or peripheral blood stem cell transplant: a decade in review. Oncol Nurs Forum. 2003a;4:613-629.
9. Cella D, Tulsky D. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest. 1993;11:327-336. (Pubitemid 23161192)
10. Andrykowski M, Bishop M, Hahn E, et al. Long-term health related quality of life, growth, and spiritual well-being after hematopoietic stemcell transplantation. J Clin Oncol. 2005;2:599-608. (Pubitemid 46224238)
11. Edman L, Larsen J, Hägglund H, Gardulf A. Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogeneic stem-cell transplantation. Eur J Cancer Care. 2001;10:124-130. (Pubitemid 33699418)
12. Marks D, Gale D, Vedhara K, Bird J. A quality of life study in 20 adult long-term survivors of unrelated donor bone marrow transplantation. Bone Marrow Transplant. 1999;24:191-195. (Pubitemid 29351834)
13. Molassiotis A, Morris P. Quality of life in patients with chronic myeloid leukaemia after unrelated donor bone marrow transplantation. Cancer Nurs. 1999;22:340-349. (Pubitemid 29466342)
14. Sutherland H, Fyles G, Adams G, et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant. 1997;19:129-136. (Pubitemid 27267738)
15. Worel N, Biener D, Kahls P, et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngenic stem cell transplantation. Bone Marrow Transplant. 2002;30:619-626. (Pubitemid 35414812)
16. Danaher Hacker E, Ferrans CE. Quality of life immediately after peripheral blood stem cell transplantation. Cancer Nurs. 2003b;26:312-321.
17. Hjermstad M, Evensen S, Kvaloy S, Fayers P, Kaasa S. Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. J Clin Oncol. 1999a;17:706-718. (Pubitemid 29075260)
18. Larsen J, Nordström G, Ljungman P, Gardulf A. Symptom occurrence, symptom intensity and symptom distress in patients undergoing high-dose chemotherapy with stem cell transplantation. Cancer Nurs. 2004;27:55-64. (Pubitemid 38155688)
19. Larsen J, Nordström G, Ljungman P, Gardulf A. Factors associated with poor general health after stem cell transplantation. Support Care Cancer. 2007;15:849-857. (Pubitemid 47387505)
20. Bevans M, Marden S, Leidy N, et al. Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006;38:101-109.
21. Dïez-Campelo M, Përez-Simön J, Gonzälez-Porras J, et al. Quality of life assessment in patient undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study. Bone Marrow Transplant. 2004;34:729-738. (Pubitemid 39406057)
22. Aaronson N, Ahmedzai S, Bergman B, et al. The European Organisation for Research and Treatment of Cancer: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376. (Pubitemid 23073154)
23. Hjermstad M, Holte H, Evensen S, Fayers P, Kaasa S. Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year? Bone Marrow Transplant. 1999b;24:911-918.
24. Andersson I, Hjermstad M, Stockelberg D, Persson LO. Health-related quality of life in stem cell transplantation. Clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19). Acta Oncol. 2008;47:275-285.
25. EORTC Quality of life study group. EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels, Belgium: EORTC; 2001.
26. Sprangers M, Cull A, Bjordal K, Groenvold M, Aaronson N. The European organization for research and treatment of cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Qual Life Res. 1993;2:287-295. (Pubitemid 23282331)
27. Fayers P, Machin D. Quality of Life: Assessment, Analysis, and Interpretation. 2nd ed. West Sussex: John Wiley & Sons Ltd; 2001.
28. Good P. Permutation Tests. New York, NY: Springer Verlag; 2000.
29. King M. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996;5:555-567. (Pubitemid 27006967)
30. Osoba D, Rodrigues G, Myes J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139-144. (Pubitemid 28041591)
31. Andrykowski M, Greiner C, Altmaier E, et al. Quality of life following bone marrow transplantation: findings from a multicentre study. Br Cancer. 1995;71:1322-1329.
32. Broers S, Kaptein A, Le Cessie S, Fibbe W, Hengeveld M. Psychological functioning and quality of life following bone marrow transplantation: a 3-year follow-up study. Psychosom Res. 2000;48:11-21. (Pubitemid 30128563)
33. Brown C, Wingard J. Clinical consequences of oral mucositis. Semin Oncol Nurs. 2004;20:16-21.
34. Hjermstad M, Knobel H, Brinch L, et al. A prospective study of healthrelated quality of life, fatigue, anxiety and depression 3Y5 years after stem cell transplantation. Bone Marrow Transplant. 2004;34:257-266. (Pubitemid 39136833)